Related Experiment Video
Updated: Aug 15, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
[Clostridium difficile ribotype 027, toxinotype III in The Netherlands]
E J Kuijper1, S B Debast, E Van Kregten
1Leids Universitair Medisch Centrum, Centrum voor Infectieziekten, Postbus 9600, 2300 RC Leiden. e.j.kuijper@lumc.nl
Abstract:
Recently, two Dutch hospitals reported outbreaks of Clostridium difficile ribotype 027, toxinotype III. This strain, which was seen earlier in the United States, Canada and the United Kingdom, produces large amounts of toxins due to a defect in the toxin-regulating gene and causes severe diarrhoea. Antibiotic use, especially use of fluoroquinolones, is a risk factor. Control of outbreaks is hampered by the fact that Clostridium forms spores that can survive for a very long time in the environment and are resistant to the usual surface disinfectants. Protocols for diagnostic investigations, prevention and control of outbreaks are available.
Related Concept Videos
Bacterial Gastroenteritis
Diphtheria
Clinical Significance of Antibiotic Resistance
Bacterial Toxins
Cholera
Botulism

